These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Verapamil in idiopathic ventricular tachycardia of right bundle branch block morphology: observations during electrophysiologic and exercise testing. Sethi KK; Manoharan S; Mohan JC; Gupta MP Pacing Clin Electrophysiol; 1986 Jan; 9(1 Pt 1):8-16. PubMed ID: 2419859 [TBL] [Abstract][Full Text] [Related]
5. Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol. Buxton AE; Waxman HL; Marchlinski FE; Josephson ME Am J Cardiol; 1984 Mar; 53(6):738-44. PubMed ID: 6702622 [TBL] [Abstract][Full Text] [Related]
6. The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysis. DiCarlo LA; Susser F; Winston SA Am Heart J; 1990 Dec; 120(6 Pt 1):1347-55. PubMed ID: 1978977 [TBL] [Abstract][Full Text] [Related]
7. Verapamil in ventricular tachycardia. Hasin Y; Kriwisky M; Gotsman MS Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466 [TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs. Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease. Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337 [TBL] [Abstract][Full Text] [Related]
10. Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil. Maggioni AP; Cavalli A; Tusa M; Volpi A Acta Cardiol; 1986; 41(6):443-9. PubMed ID: 3492843 [TBL] [Abstract][Full Text] [Related]
11. Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity. Sung RJ; Shapiro WA; Shen EN; Morady F; Davis J J Clin Invest; 1983 Jul; 72(1):350-60. PubMed ID: 6874951 [TBL] [Abstract][Full Text] [Related]
12. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia. Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883 [TBL] [Abstract][Full Text] [Related]
13. Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease. Lee KL; Lauer MR; Young C; Lai WT; Tai YT; Chun H; Liem LB; Sung RJ Am J Cardiol; 1996 May; 77(11):967-73. PubMed ID: 8644647 [TBL] [Abstract][Full Text] [Related]
14. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability. Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666 [TBL] [Abstract][Full Text] [Related]
15. Sustained ventricular tachycardia responsive to verapamil in patients with hypertrophic cardiomyopathy. Clinical and electrophysiological assessment of drug efficacy. Miyajima S; Aizawa Y; Suzuki K; Satoh M; Niwano S; Ebe K; Fujita T; Ishiguro J; Hirokawa Y; Shibata A Jpn Heart J; 1989 Mar; 30(2):241-9. PubMed ID: 2724542 [TBL] [Abstract][Full Text] [Related]
16. Entrainment of idiopathic ventricular tachycardia of left ventricular origin with evidence for reentry with an area of slow conduction and effect of verapamil. Okumura K; Matsuyama K; Miyagi H; Tsuchiya T; Yasue H Am J Cardiol; 1988 Oct; 62(10 Pt 1):727-32. PubMed ID: 3421173 [TBL] [Abstract][Full Text] [Related]
17. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. Lerman BB; Waxman HL; Buxton AE; Josephson ME Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435 [TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357 [TBL] [Abstract][Full Text] [Related]
20. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia]. Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]